Pathology Watch, a Salt Lake City-based life sciences company, has been acquired by Sonic Healthcare, a Sydney, Australia-headquartered healthcare company. The $150 million deal is expected to close this month.
Sonic said the acquisition a strategic move that will help its transition to digital pathology services. Pathology Watch is at the pre-profit stage, but Sonic expects its earnings-per-share and return-on-invested-capital to grow in the coming years, according to a release from the company.
Pathology Watch’s founders, management and staff will join Sonic’s U.S. and global operations.
“The acquisition of Pathology Watch is an important and Please log in to see the rest of this story.
